Jeremy Roma pitches Daisy victims on new EndoTech AI grift
With BioLimitless failing to recapture Daisy Ponzi victims, co-conspirators Jeremy Roma, Eduard Khemchan and Ilya Martin have come up with a new ruse.
On July 21st Roma fronted a “Daisy updates” webinar, pitching Daisy Ponzi victims on a new AI grift from EndoTech.
EndoTech’s purported new ruse is “AI Agents”.
“AI agents” is just a fancy sounding name for an “AI chatbot”. To quote Jeremy Roma;
In the case of EndoTech … we’re able to launch this AI Agent business model to the entire world and incorporate that in the financial markets.
If a person is a trader … imagine being able to be in the middle of a trade and you’re subscribing to specific AI Agents.
You’re able to interact with those agents while your in the middle of the charts. You’re able to analyze.
The ruse pitched to Daisy victims is that EndoTech is going to sell access to its AI Agents to other companies. Although it’s not publicly listed anywhere and legally unable to issue shares, Roma represents Daisy holds a 22% equity stake in EndoTech.
Daisy victim losses will thus be funded by the sale of AI Agents. Although I’m sure Daisy victims will at some point be asked for more money.
Individuals will be able to come in and subscribe to this AI service.
A longer-term carrot Roma dangles infront of Daisy victims is the prospect that EndoTech will either go public or be sold off to buyers unknown for “two billion dollars”.
As EndoTech wins, as EndoTech has revenue and profits, as EndoTech goes public, as EndoTech sells and finds the right partners, every time something great happens for EndoTech, something great is happening for the Daisy community.
As shareholders in EndoTech, the next big thing for all of us is to share in the dividends.
The mission and the goal of an IPO, a public offering with EndoTech, or a buyout with a major company, right? That may come in and say, “We’ll give you two billion dollars for this AI technology and we want to buy out the company.” That’s a win for the entire community.
This of course isn’t EndoTech first AI grift. Daisy Forex in 2022 was marketed on the premise EndoTech had AI bots trading crypto (that scheme collapsed in December 2023).
Roma claims what will be the sixth Daisy Ponzi reboot, is scheduled to launch “by September”.
In January 2024 the SEC issued an investor alert warning consumers of fraudulent investment schemes utilizing AI marketing ruses.
The Securities and Exchange Commission (SEC) Office of Investor Education and Advocacy, the North American Securities Administrators Association (NASAA), and the Financial Industry Regulatory Authority (FINRA) are jointly issuing this Investor Alert to make investors aware of the increase of investment frauds involving the purported use of artificial intelligence (AI) and other emerging technologies.
Individual investors should know that bad actors are using the growing popularity and complexity of AI to lure victims into scams.
First and foremost, investors should remember that federal, provincial, and state securities laws generally require securities firms, professionals, exchanges, and other investment platforms to be registered.
A promoter’s lack of registration status should be taken as a prompt to do additional investigation before you invest any money.
Although the majority of Daisy investors are believed to be US residents, Neither Daisy, Jeremy Roma, Eduard Khemchan, Ilya Martin or EndoTech are registered with the SEC.
As part of continued efforts to dissuade public discussion and/or filing reports with the SEC and other authorities (BehindMLM last documented gaslighting of Daisy victims a year ago), Roma threatens Daisy victims with legal action.
Any accusation that something wrong has been done, something unethical has been done, is a false accusation.
It is defamation of character for anyone to say that the three of us as founders, or any of the leaders in the Daisy project, were doing something other than what we told the community, showed the community was being done.
This is absolutely fraudulent activity. And it’s unfortunate that there are some small groups of people out there who have actually tied to blackmail us.
They have literally tried to threaten against us as founders. They actually believed they could squeeze money from us personally if they somehow made us feel threatened.
Understand that that will never work with us. We will never allow a bad actor to receive some benefit before all of you, the good actors, get what is coming to you.
Unfortunately these type of tactics also require our law firm to get involved. They require us to to go out and file lawsuits in other countries. To hire law firms and attorneys in those countries and to go take legal action against the people that are trying to threaten this community.
Roma doesn’t provide any evidence to support his claims. In March 2025 Roma pegged Daisy victim losses at at least $1.1 billion.
For those unfamiliar with EndoTech, it’s a purported Israeli firm co-founded by Anna Becker and Dmitry Gushchin (aka Gooshchin).
EndoTech has been at the center of multiple MLM investment frauds. Including Daisy Forex circa late 2022, EndoTech is also tied to iGenius.
iGenius is owned by Investview, a US company who settled fraud charges with the SEC earlier this year. Jeremy Roma is a former Investview executive.
Belgium issued an EndoTech fraud warning May 2021. iGenius recently attracted regulatory attention from Canada and Poland.
When did the relationship between Roma and Eric Nepute go south? I suspect it was very soon after the so-called launch.
Probably when the money didn’t manifest. Haven’t seen a coverup ruse for BioLimitless yet. Suppose they’ll have to trot one out at some point.
My bet is they’ll ignore it like it never existed.
“We need to come up with something for our Daisy victims! Release the funds!”
“BioLimitless is gonna launch soon!”
“Relax guys, I have the BioLimitless launch papers on my desk. We’re almost ready.”
“BioLimitless never existed. The launch papers were a hoax. We’re not releasing the Daisy funds.”
“I can’t believe you’re still talking about BioLimitless and the Daisy funds. Nobody cares about BioLimitless. The Daisy funds is so boring. Daisy died years ago and people are still wasting time on it?”
“If you’re still talking about BioLimitless and the Daisy funds you’re not part of this community. Look over there, aI aGenTs!”
In Israel, information about shareholders and directors of both private and public companies is generally part of the public record and is available for a small fee. So at least the claimed ownership stake should be verifiable (not that I’m going to pay the fee to check).
The amount of blind trust people put into these guys just boggles my mind.